Presently, Medicare is forbidden by law from paying for antiobesity prescriptions. But should the bipartisan The Treat and Reduce Obesity Act get reintroduced and passed by Congress, Medicare will be compelled to cover drugs for weight loss.
https://www.pharmalive.com/wp-content/uploads/2020/10/U.S.-strikes-deal-with-Lilly-for-potential-COVID-19-antibody-drug-Reuters-10-28-20.jpeg246370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-11 07:46:012023-03-13 10:55:39Economists warn of costs if Medicare covers new obesity drugs
